<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03959748</url>
  </required_header>
  <id_info>
    <org_study_id>1/BNP-PL/2018</org_study_id>
    <nct_id>NCT03959748</nct_id>
  </id_info>
  <brief_title>DataBase of pulmoNary hyPertesion in PoLish Population - BNP-PL</brief_title>
  <acronym>BNP-PL</acronym>
  <official_title>DataBase of pulmoNary hyPertesion in PoLish Population - BNP-PL</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Polish Cardiology Association</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Jagiellonian University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Polish Cardiology Association</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The BNP-PL is a multicenter, observational study in which patients are prospectively followed
      in order to investigate clinical course and management of pulmonary hypertension in Poland.

      All patients diagnosed with pulmonary arterial hypertension and chronic thromboembolic
      pulmonary hypertension confirmed in right heart catheterization, will be eligible to
      participate in the study.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The BNP-PL Registry is an initiative of the Polish Cardiac Society Task Force for Pulmonary
      Vascular Diseases This study is conducted by the Polish Cardiac Society. All centers of
      pulmonary hypertension in Poland which are accredited by the National Health Fund have been
      invited to join the study. The data is administrated by the Jagiellonian University Medical
      College on the basis of an agreement between the Polish Cardiac Society, Jagiellonian
      University Medical College and pulmonary hypertension centres.

      The goal is to describe current practice and outcomes in patients with pulmonary arterial
      hypertension and chronic thromboembolic pulmonary hypertension.

      The data collection will have no impact on the way the patient is diagnosed and treated.

      Collection of data on patients with pulmonary hypertension is carried out via the electronic
      platform.

      No personal data is entered into the project database.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 1, 2018</start_date>
  <completion_date type="Anticipated">February 28, 2028</completion_date>
  <primary_completion_date type="Anticipated">February 28, 2023</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>5 Years</target_duration>
  <primary_outcome>
    <measure>Mortality</measure>
    <time_frame>Since enrollment until at least 5 years.</time_frame>
    <description>The number of patients who die during the follow-up period</description>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">3000</enrollment>
  <condition>Chronic Thromboembolic Pulmonary Hypertension</condition>
  <condition>Pulmonary Arterial Hypertension</condition>
  <arm_group>
    <arm_group_label>PAH adults</arm_group_label>
    <description>Patients with pulmonary arterial hypertension who are at least 18 years old at study entry</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PAH children</arm_group_label>
    <description>Patients with pulmonary arterial hypertension who are at least 3 months old and are less than 18 years old at study entry</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CTEPH</arm_group_label>
    <description>Patients with chronic thromboembolic pulmonary hypertension who are at least 18 years old at study entry</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary
        hypertension treated in Polish centres of pulmonary hypertension accredited by the National
        Health Fund
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary
        hypertension diagnosed after 1st March 2018 (incident cases) who:

          -  are aged &gt; 3 months at the time of enrollment

          -  fulfill the following hemodinamic criteria: mean pulmonary arterial pressure (mPAP) of
             25 mm Hg or more, mean pulmonary arterial wedge pressure (PAWP) or left ventricular
             end-diastolic pressure (PVEDP) of 15 mm Hg or less, pulmonary vascular resistance
             (PVR) of 3 Woods.

        Patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary
        hypertension diagnosed before 1st March 2018 (prevalent cases) who:

          -  are aged &gt; 3 months at the time of enrollment

          -  fulfill the following hemodinamic criteria: mean pulmonary arterial pressure (mPAP) of
             25 mm Hg or more, mean pulmonary arterial wedge pressure (PAWP) or left ventricular
             end-diastolic pressure (PVEDP) of 15 mm Hg or less, pulmonary vascular resistance
             (PVR) of 3 Woods
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Months</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Grzegorz Kopeć, MD, Phd</last_name>
    <role>Principal Investigator</role>
    <affiliation>Krakowski Szpital Specjalistyczny im. Jana Pawła II</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Grzegorz Kopeć</last_name>
    <phone>+48 12 614 33 99</phone>
    <email>grzegorzkrakow1@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Magdalena Studnicka</last_name>
    <phone>+48 602460707</phone>
    <email>mstudnicka@medicalartgroup.pl</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Krakowski Szpital Specjalistyczny im. Jana Pawła II</name>
      <address>
        <city>Kraków</city>
        <zip>31-202</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Grzegorz Kopeć</last_name>
      <phone>+48 126143399</phone>
      <email>grzegorzkrakow1@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Poland</country>
  </location_countries>
  <verification_date>May 2019</verification_date>
  <study_first_submitted>March 26, 2019</study_first_submitted>
  <study_first_submitted_qc>May 20, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 22, 2019</study_first_posted>
  <last_update_submitted>May 20, 2019</last_update_submitted>
  <last_update_submitted_qc>May 20, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">May 22, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Pulmonary Hypertension,</keyword>
  <keyword>CTEPH</keyword>
  <keyword>Pulmonary Arterial Hypertension</keyword>
  <keyword>Registry</keyword>
  <keyword>Data Base</keyword>
  <keyword>Polish patients</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension, Pulmonary</mesh_term>
    <mesh_term>Hypertension</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

